Relationship between phenotypes of cell-function differentiation and pathobiological behavior of gastric carcinomas

Table 4 Relationship between cell-function and WHO’s histological classifications of gastric carcinoma

Types	n	AFDT (%)	MSFDT (%)	AMPFDT (%)	SFDT (%)	NFDT (%)
Papillary adenocarcinoma	37	29 (78.4)a	2 (5.4)	6 (16.2)	0	0
Tubular adenocarcinoma
Well-diff. ade.	20	17 (85.0)	0	2 (10.0)	0	1 (5.0)
Mode. diff. ade.	59	20 (33.9)	5 (8.5)	27 (45.8)	1 (1.7)	6 (10.2)
Poor. diff. ade.	126	15 (11.9)	14 (11.1)	79 (62.7)	2 (1.6)	16 (12.7)
Undiff. car.	30	1 (3.3)	7 (23.3)	13 (43.3)	0	9 (30.0)
SRC	41	0	5 (12.2)	6 (87.8)b	0	0
Mucous ade.	38	0	21 (55.3)	17 (44.7)	0	0
Carcinoid	9	0	0	0	9 (100.0)	0
Squamous car.	1	0	0	0	1 (100.0)	0
Total	361	82 (22.7)	54 (15.0)	180 (49.9)	13 (3.6)	32 (8.9)

^aP < 0.01 (χ² = 28.6784), vs others of the papillary adenocarcinomas;

^bP < 0.01 (χ² = 46.8780), vs others of signetring cell carcinomas. ade: Adenocarcinoma; diff.: Differentiated; mode.: Moderately; undiff.: Undifferentiated; SRC: Signet ring cell carcinoma